Bibliographie (2362)
Answering key questions about COVID-19 vaccines
lundi, 19 octobre 2020 01:18 Écrit par Zouhair SouissiAnswering Key Questions About COVID-19 Vaccines – JAMA Commentary on Twitter Many individuals are hesitant about receiving #COVID19 vaccines. It is critical that clinicians stay well informed about emerging data so that they can help patients make sound decisions https://t.co/1QDwOKuDqc @JesseGoodmanMD @ImmunizeOrg @pharmacists — JAMA (@JAMA_current) October 16, 2020
The post Answering key questions about COVID-19 vaccines appeared first on Links Medicus.
New studies show reduced prevalence and severity of SARS-CoV-2 infection in ABO blood group O
lundi, 19 octobre 2020 01:18 Écrit par Zouhair SouissiStudy 1: Reduced prevalence of SARS-CoV-2 infection in ABO blood group O – Blood Advances Study 2: The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 – Blood Advances Commentaries: People with blood type O may have lower risk of Covid-19 infection and severe illness, two new studies […]
The post New studies show reduced prevalence and severity of SARS-CoV-2 infection in ABO blood group O appeared first on Links Medicus.
NIHR dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid)
lundi, 19 octobre 2020 01:18 Écrit par Zouhair SouissiA dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) – National Institute for Health Research News Release: Living with COVID: NIHR publishes dynamic themed review into ‘ongoing COVID’ Commentaries: Coronavirus: ‘Long Covid could be four different syndromes’ – BBC AND Long covid could be four different syndromes, review suggests – […]
The post NIHR dynamic review of the evidence around ongoing Covid19 symptoms (often called Long Covid) appeared first on Links Medicus.
Improving prone positioning for severe ARDS during the COVID-19 pandemic: An implementation mapping approach
lundi, 19 octobre 2020 01:18 Écrit par Zouhair SouissiImproving Prone Positioning for Severe ARDS during the COVID-19 Pandemic: An Implementation Mapping Approach – Annals of the American Thoracic Society Commentary: Study examines ways to improve prone positioning for severe ARDS during COVID-19 pandemic – News Medical / American Thoracic Society Commentary on Twitter Improving Prone Positioning for Severe ARDS during the COVID-19 […]
The post Improving prone positioning for severe ARDS during the COVID-19 pandemic: An implementation mapping approach appeared first on Links Medicus.
Updated Cochrane Review shows electronic cigarettes can help people quit smoking
vendredi, 16 octobre 2020 11:51 Écrit par Zouhair SouissiUpdated Cochrane Review shows electronic cigarettes can help people quit smoking – Cochrane Library Original study: Electronic cigarettes for smoking cessation – Cochrane Library Commentary on Twitter How do electronic cigarettes compare with other methods of trying to #QuitSmoking? Here's the latest Cochrane evidence from @CochraneTAG: https://t.co/H4Q2n9bYHN #Stoptober. #smoking pic.twitter.com/uIYC7p1sqy — Cochrane UK (@CochraneUK) […]
The post Updated Cochrane Review shows electronic cigarettes can help people quit smoking appeared first on Links Medicus.
Randomized trial: Effect of sustained smoking cessation counseling and free medication vs. shorter-term counseling and medication advice on smoking abstinence
vendredi, 16 octobre 2020 11:51 Écrit par Zouhair SouissiEffect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial – JAMA Commentary: Long-term, frequent phone counseling helps cancer patients who smoke quit – eCancer
The post Randomized trial: Effect of sustained smoking cessation counseling and free medication vs. shorter-term counseling and medication advice on smoking abstinence appeared first on Links Medicus.
Cochrane living systematic review: Not enough evidence to recommend convalescent plasma for people with COVID‐19
vendredi, 16 octobre 2020 11:51 Écrit par Zouhair SouissiConvalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review – Cochrane Library Commentary on Twitter Just updated: @CochraneCollab living review investigates the use of convalescent plasma to treat people with COVID-19: https://t.co/Or5qmxki8H “We remain very uncertain about the effectiveness & safety of using convalescent plasma for people with #COVID19". — […]
The post Cochrane living systematic review: Not enough evidence to recommend convalescent plasma for people with COVID‐19 appeared first on Links Medicus.
Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic
vendredi, 16 octobre 2020 11:51 Écrit par Zouhair SouissiSensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic – JAMA Author interview: Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic Commentary on Twitter Has #COVID19 changed how you practice #medicine?.More Aggressive? Gentle? Humble? or Nihilistic?.Check out @JAMA_current elevating a discussion of Sensible Medicine.https://t.co/IfXVktCMJb @UPMC @UPMCnews @ErinMcCreary @PittCCM @PittTweet — Christopher Seymour (@seymoc) […]
The post Viewpoint: Sensible medicine—balancing intervention and inaction during the COVID-19 pandemic appeared first on Links Medicus.
Scientific consensus on the COVID-19 pandemic: we need to act now
vendredi, 16 octobre 2020 11:51 Écrit par Zouhair SouissiScientific consensus on the COVID-19 pandemic: we need to act now – The Lancet Commentary: Herd immunity approaches to COVID-19 control are a ‘dangerous fallacy’, say authors of open letter – The Lancet
The post Scientific consensus on the COVID-19 pandemic: we need to act now appeared first on Links Medicus.
![[Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19](/media/k2/items/cache/18325a37bf525b9d88d51a3441669c72_S.jpg)
[Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19
vendredi, 16 octobre 2020 11:51 Écrit par Zouhair SouissiRepurposed antiviral drugs for COVID-19; interim WHO SOLIDARITY trial results – medRxiv Commentaries on Twitter Results of the @WHO SOLIDARITY trial: 4 drugs tested in 11,266 patients with COVID in 405 hospitals in 30 countries:– hydroxychloroquine – lopinavir– remdesevir – interferon No clear benefit of any of them on survival. https://t.co/ohtTAFaSnc pic.twitter.com/2fO9E8zs8h — Martin […]
The post [Preprint] WHO SOLIDARITY trial results published; Remdesivir, Hydroxychloroquine, Lopinavir, and Interferon do not improve outcomes in Covid-19 appeared first on Links Medicus.
